Adaptimmune Therapeutics shares owned by MPM Asset Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by MPM Asset Management
from 13F filings
Historical chart of MPM Asset Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by MPM Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by MPM Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.4M | 5.6M | 0.98 |
| 2024-03-31 | $8.8M | 5.6M | 1.58 |
| 2023-09-30 | $4.9M | 6.3M | 0.78 |
| 2023-06-30 | $5.8M | 6.3M | 0.93 |